Investing.com - Biora Therapeutics reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Biora Therapeutics announced earnings per share of $-0.030 on revenue of $80K. Analysts polled by Investing.com anticipated EPS of $-0.080 on revenue of $100K.
Biora Therapeutics shares are down 81% from the beginning of the year, still down 95.47% from its 52 week high of $6.20 set on November 17, 2021.
Biora Therapeutics shares gained 4.98% in after-hours trade following the report.
Biora Therapeutics follows other major Healthcare sector earnings this month
Biora Therapeutics's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar